New digital platform launched to assist clinical trials
A Dublin-based start-up has developed a new digital platform used for the effective organisation of clinical trials. Wirano is the name of the platform which aims to revolutionise the processes involved in the preparation and set-up of various medical or medtech trials. It is designed to accelerate the start-up of trials, optimising patient recruitment and improving site and investigator selection processes. Clinical trials are expensive, time-costly processes, meaning that any systems of technologies that can reduce costs and time wastage are invaluable tools. "The enormous cost of clinical trials in terms of time, money and effort is well known. The average clinical trial process lasts between 7.5 and 12 years with costs ranging from $161 million - $2.6 billion per drug”, said Noel Quinn, commercial director.
The platform will be of interest to many organisations who are embarking on clinical trials of large sizes. A standout reason for the adoption of the platform by clinical trial organisers is its ability to co-ordinate and optimise the patient recruitment process. 50% of all planned clinical trials do not achieve their recruitment targets by their goal time. Strikingly, up to 11% of trials do not recruit a single patient. A lack of database of research centres available to organisations is also a hurdle. Wirano is designed to allow all participants of clinical trials, including pharmaceutical companies, medical researchers, and patients to effectively communicate throughout the process.
International experts of clinical research collaborated on the Wirano platform since its inception, the team is now seeking investors to propel the project forward for expansion.